Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Capital Expenditures: 2013-2018

Historic Capital Expenditures for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2018 value amounting to $391,000.

  • Armata Pharmaceuticals' Capital Expenditures rose 2072.22% to $391,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $597,000, marking a year-over-year increase of 929.31%. This contributed to the annual value of $1.9 million for FY2024, which is 76.93% down from last year.
  • As of Q4 2018, Armata Pharmaceuticals' Capital Expenditures stood at $391,000, which was up 152.26% from $155,000 recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Capital Expenditures peaked at $831,000 during Q2 2014, and registered a low of $2,000 during Q2 2017.
  • Its 3-year average for Capital Expenditures is $88,300, with a median of $31,000 in 2016.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 98.92% in 2015, then skyrocketed by 2,072.22% in 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Capital Expenditures (Quarterly) stood at $5,000 in 2014, then skyrocketed by 900.00% to $50,000 in 2015, then tumbled by 74.00% to $13,000 in 2016, then skyrocketed by 38.46% to $18,000 in 2017, then spiked by 2,072.22% to $391,000 in 2018.
  • Its Capital Expenditures was $391,000 in Q4 2018, compared to $155,000 in Q3 2018 and $18,000 in Q4 2017.